The Growth in this market is driven mainly by the rapid growth in the geriatric population and the associated increase in the prevalence of coronary artery diseases, the growing preference for minimally invasive surgeries and approval of new and advanced products.
According to the new market research report Interventional Cardiology Devices Market is projected to reach USD 21.2 billion by 2025 from USD 13.8 billion in 2020, at a CAGR of 8.9%.
In 2019, the old/normal balloons segment accounted for the largest share of the angioplasty balloons market. Based on type, the angioplasty balloons market is segmented into old/normal balloons, cutting and scoring balloons, and drug-eluting balloons. The large share of this segment can be attributed to a increasing its use in impating the stents and structural heart devices; and increasing prevalence of vaulvuloplasty.
Some of the major players in the interventional cardiology devices market include Medtronic (US), iVascular (Spain), Edward Lifescinces Corporation (US), Boston Scientific Corporation (US), Abbott (US), Cardinal Health (US), B. Braun Melsungen (Germany), Terumo Corporation (Japan), Biosensors International Group (Singapore), and BIOTRONIK SE & Co. KG (Germany).
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=548